Literature DB >> 14624757

The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice.

David Liñares1, Paula Mañá, Melinda Goodyear, Anne M Chow, Chelsea Clavarino, Nicholas D Huntington, Louise Barnett, Frank Koentgen, Ryo Tomioka, Claude C A Bernard, Manuel Freire-Garabal, Hugh H Reid.   

Abstract

Myelin oligodendrocyte glycoprotein (MOG) is a minor component of central nervous system myelin presumably implicated in the pathogenesis of Multiple Sclerosis (MS). Immunization with MOG leads to the development of Experimental Autoimmune Encephalomyelitis (EAE), the experimental model of MS. It has been suggested that its encephalitogenic potential may be due to the lack of MOG self-immune tolerance. To clarify this, we have generated a MOG deficient mouse (MOG(-/-)) strain. Surprisingly, MOG(35-55)specific proliferation and Th1-type cytokine production were markedly enhanced in MOG(-/-)mice compared to wild type control. Furthermore, adoptive transfer of MOG(35-55)specific T cells, isolated from MOG deficient mice, into wild-type recipients resulted in the development of a more severe disease, indicating a high capacity of MOG(-/-)T cells to initiate effector responses. Interestingly, T cell reactivity to overlapping MOG peptides in MOG(-/-)mice did not reveal new potential immunodominant epitopes in H-2(b)mice. Taken together, our data suggests that MOG self-tolerance modulates the encephalitogenic potential of autoreactive MOG T cells in the periphery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624757     DOI: 10.1016/j.jaut.2003.09.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes.

Authors:  Xuejun Zhang; Jin-Qing Liu; Yun Shi; Hugh H Reid; Richard L Boyd; Mazin Khattabi; Hani Y El-Omrani; Pan Zheng; Yang Liu; Xue-Feng Bai
Journal:  Eur J Immunol       Date:  2012-01-19       Impact factor: 5.532

2.  A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy.

Authors:  Hyun Hor; Luca Bartesaghi; Zoltán Kutalik; José L Vicário; Clara de Andrés; Corinne Pfister; Gert J Lammers; Nicolas Guex; Roman Chrast; Mehdi Tafti; Rosa Peraita-Adrados
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

3.  NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.

Authors:  Lori Blanchfield; Joseph J Sabatino; Laurel Lawrence; Brian D Evavold
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

4.  Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.

Authors:  Maria Bettini; Kristen Rosenthal; Brian D Evavold
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

Review 5.  Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

Authors:  Markus Reindl; Patrick Waters
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

Review 6.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

Authors:  Bert A 't Hart; Yvette van Kooyk; Jeroen J G Geurts; Bruno Gran
Journal:  Ann Clin Transl Neurol       Date:  2015-03-18       Impact factor: 4.511

7.  Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.

Authors:  Aparna Shetty; Sheena G Gupta; Michel Varrin-Doyer; Martin S Weber; Thomas Prod'homme; Nicolas Molnarfi; Niannian Ji; Patricia A Nelson; Juan C Patarroyo; Ulf Schulze-Topphoff; Stephen E Fogal; Thomas Forsthuber; Raymond A Sobel; Claude C A Bernard; Anthony J Slavin; Scott S Zamvil
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-08-14

8.  Low-affinity CD4+ T cells are major responders in the primary immune response.

Authors:  Ryan J Martinez; Rakieb Andargachew; Hunter A Martinez; Brian D Evavold
Journal:  Nat Commun       Date:  2016-12-15       Impact factor: 14.919

Review 9.  Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.

Authors:  Patrick Peschl; Monika Bradl; Romana Höftberger; Thomas Berger; Markus Reindl
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

10.  The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.

Authors:  H-Christian von Büdingen; Feng Mei; Ariele Greenfield; Sarah Jahn; Yun-An A Shen; Hugh H Reid; David D McKemy; Jonah R Chan
Journal:  J Cell Biol       Date:  2015-09-14       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.